Completed PHASE3 INTERVENTIONAL NCT00128167

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6-59 Months of Age

Sponsor: MedImmune LLC

Conditions Influenza

Interventions Liquid CAIV-T

Updated 9 times since 2017 Last updated: Sep 10, 2021 Started: Oct 31, 2004 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Influenza, this trial is completed. The trial is conducted by MedImmune LLC and has accumulated 9 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Oct 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Completed PHASE3
Sep 2020 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Sep 2020 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MedImmune LLC

Data source: MedImmune LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Antwerp, Belgium , Atlanta, United States , Austin, United States , Ayr, United Kingdom , Ayrshire, United Kingdom , Bangor County, Ireland , Bardstown, United States , Barnsely, United Kingdom , Barrington, United States and 133 more locations